HCR’s team is exploring therapeutic possibilities where tissue targeting and loading of different drug cargoes into exosomes can have a transformative effect on untreated diseases and symptoms.

Enormous potential exists within the scope of diseases that contain significant inflammatory and autoimmune components, whether they are conferred by genetics, environment, immune system stressors or their combination. HCR team is working on a diversified clinical development pipeline in multiple diseases area aiming to bring innovative and accessible EVs therapeutics for skincare, drug delivery, cell regeneration and immune regulators.